Bsx nyse.

BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 68.77 ( 12/01/23) EPS (TTM) $0.82 Market Cap $82.24 B... MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – Research Report) on March 2 and set a price ta... RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – ...MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...

Get the latest Boston Scientific Corporation (BSX) stock news and headlines to help you in your trading and investing decisions.

In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.

We think that Boston Scientific stock (NYSE: BSX) currently is a better pick compared to its industry peer, Medtronic stock (NYSE: MDT), despite it being the more expensive of the two, trading at ...WebNov 28, 2023 · Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices. According to the latest 13F filings, Millennium Management owned 11 million shares of Boston Scientific Corporation (NYSE ... Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, has recently ventured into chronic pain management.The company’s strategic acquisition of ... Boston Scientific Announces Results For Fourth Quarter and Full Year 2021. Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational1 basis...Boston Scientific Corp. BSX (U.S.: NYSE) search. View All companies ` AT CLOSE 4:00 PM ... decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and ...

Oct 19, 2023 · On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...

BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.

MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...27 Jul, 2021, 06:30 ET. MARLBOROUGH, Mass., July 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.077 billion during the second quarter of 2021, growing ...Boston Scientific's (BSX) Wicked Rally Can Take the Stock 20% Higher Boston Scientific (BSX) made a new 52-week high on Tuesday. Can this advance keep going? Let's check the position of the charts and the condition of the indicators. In...BSX 30-Year Financial Data. The intrinsic value of BSX. Boston Scientific is a leading producer of less invasive medical devices that are inserted into the human body through small openings or cuts.Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates.

Boston Scientific Revenue. Boston Scientific had revenue of $13.40B in the twelve months ending June 30, 2023, with 8.69% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $3.60B with 10.94% year-over-year growth. In the year 2022, Boston Scientific had annual revenue of $12.68B with 6.68% growth.WebFOURTH QUARTER AND FULL YEAR 2022. Marlborough, Mass. (February 1, 2023) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year …WebBoston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports.The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target …WebGet real-time Boston Scientific (BSX) stock price quotes, analyst insights ... Tech Sector Has Lots to Prove as Earnings Loom Following Strong Q1 Stock Market.Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions.

MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ...Dec 1, 2023 · Financial Performance. In 2022, BSX's revenue was $12.68 billion, an increase of 6.68% compared to the previous year's $11.89 billion. Earnings were $642.00 million, a decrease of -34.82%. Financial Statements. 9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.The company's devices are marketed globally to healthcare professionals and institutions, with foreign sales accounting for nearly half of its total sales. Currently, Boston Scientific ( NYSE:BSX ...Dec 1, 2023 · See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions. Boston Scientific's (BSX) Wicked Rally Can Take the Stock 20% Higher Boston Scientific (BSX) made a new 52-week high on Tuesday. Can this advance keep going? Let's check the position of the charts and the condition of the indicators. In...Mount Lucas Management LP bought a new position in Boston Scientific Co. ( NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The ...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...

MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ...

Boston Scientific ( NYSE: BSX) and Shockwave Medical ( NASDAQ: SWAV) traded flat in the pre-market Monday as UBS said that a potential buyout deal between the two companies was unlikely, contrary ...

BSX NYSE. BSX NYSE. Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . BSX chart. Today 0.36% 5 days 1 ...Boston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany Participants. Lauren Tengler - Vice President, Investor Relations. Mike Mahoney ...BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 68.77 ( 12/01/23) EPS (TTM) $0.82 Market Cap $82.24 B...BSX stock has seen extremely strong gains of 55% from levels of $35 in early January 2021 to around $55 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period. BSX is ...ANET Stock, BSX, LULU, ZS And 10 Other Tickers Pop Onto IBD Watchlists Boston Scientific Reaches 80-Plus Relative Strength Rating Benchmark Boston Scientific Offers Bullish Guidance And Briefly ...RE. UBS Raises Boston Scientific Price Target to $67 From $66, Maintains Buy Rating. 10-27. MT. Oppenheimer Adjusts Boston Scientific Price Target to $58 From $59, Maintains Perform Rating. 10-27. MT. Needham Adjusts Price Target on Boston Scientific to $60 From $65, Maintains Buy Rating. 10-27.Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If that ...RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – Research Report) on March 2 and set a price ta... RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – ...Ticker Symbol: BSX: Exchange: NYSE: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0000885725: CUSIP Number: 101137107: ISIN Number: US1011371077 ...WebNov 22, 2023 · In the last trading session, 7.23 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $55.32 changed hands at $0.86 or 1.58% during last session, the market valuation stood at $81.04B. BSX’s last price was a ... See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Market Activity. Funds + ETFs. After-Hours Quotes. Investing Lists. News + Insights. P/E & PEG Ratios. ©2021, EDGAR®Online, a division of Donnelley Financial …

Boston Scientific Corp stock price (BSX). NYSE: BSX. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion ...NYSE Composite Today: Get all information on the NYSE Composite Index including historical chart, news and constituents. Indices Commodities Currencies StocksBoston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyDec 4, 2023 · Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the medical equipment provider's stock, valued at ... Instagram:https://instagram. lvhm stockeasiest mortgage lender for self employedwhat brokers trade futuresfractional investing real estate Recently. Price. BSX. 53.91. Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. forex in usamsft dividend 19 Sept 2023 ... MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a ...1.46b. PB Ratio. 4.353. Bid. 56.11. Bid Size. 2500. VWAP. 55.96737. Ask. 56.12. Ask Size. 200. Exchange. NYSE. Dividend. -. Ex-Div Date. -. Yield. N/A. Div. kass doug 1.46b. PB Ratio. 4.353. Bid. 56.11. Bid Size. 2500. VWAP. 55.96737. Ask. 56.12. Ask Size. 200. Exchange. NYSE. Dividend. -. Ex-Div Date. -. Yield. N/A. Div.Analyst Price Forecast Suggests 5.15% Upside. As of April 7, 2023, the average one-year price target for Boston Scientific is $54.43. The forecasts range from a low of $45.45 to a high of $63.00 ...Web